HK1130663A1 - Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals - Google Patents

Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals

Info

Publication number
HK1130663A1
HK1130663A1 HK09108562.2A HK09108562A HK1130663A1 HK 1130663 A1 HK1130663 A1 HK 1130663A1 HK 09108562 A HK09108562 A HK 09108562A HK 1130663 A1 HK1130663 A1 HK 1130663A1
Authority
HK
Hong Kong
Prior art keywords
micron
humans
animals
prevention
treatment
Prior art date
Application number
HK09108562.2A
Other languages
English (en)
Chinese (zh)
Inventor
Ralph Walker
Original Assignee
Natural Ma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Natural Ma Inc filed Critical Natural Ma Inc
Publication of HK1130663A1 publication Critical patent/HK1130663A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/20—Inorganic substances, e.g. oligoelements
    • A23K20/30—Oligoelements
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/10—Feeding-stuffs specially adapted for particular animals for ruminants
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/015—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16—Inorganic salts, minerals or trace elements
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/04—Sulfur, selenium or tellurium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1664—Compounds of unknown constitution, e.g. material from plants or animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
HK09108562.2A 2006-06-02 2009-09-18 Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals HK1130663A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US80373106P 2006-06-02 2006-06-02
US80561906P 2006-06-23 2006-06-23
PCT/CA2007/000977 WO2007140588A1 (fr) 2006-06-02 2007-06-04 Atténuation d'un agent pathogène par l'administration d'un composé équilibiotique

Publications (1)

Publication Number Publication Date
HK1130663A1 true HK1130663A1 (en) 2010-01-08

Family

ID=38800998

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09108562.2A HK1130663A1 (en) 2006-06-02 2009-09-18 Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals

Country Status (11)

Country Link
US (2) US20100172992A1 (fr)
EP (1) EP2035018B1 (fr)
JP (2) JP2009538837A (fr)
KR (1) KR101462090B1 (fr)
CN (1) CN101500584B (fr)
AU (1) AU2007257286B2 (fr)
CA (1) CA2654082C (fr)
HK (1) HK1130663A1 (fr)
MX (1) MX2008015200A (fr)
NZ (1) NZ597657A (fr)
WO (1) WO2007140588A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014003288A (es) * 2011-09-14 2017-03-09 Nuevas Alternativas Naturales S A P I De C V Preparacion y composiciones de azufre con valencia cero, altamente bio-disponibles, y sus usos.
CN104069089A (zh) * 2014-06-18 2014-10-01 上海大学 木质素的新用途
CA3050761A1 (fr) * 2018-07-26 2020-01-26 Attenubiotics Inc. Methode et utilisation de compositions comprenant un lignosulfonate et essentiellement libre de soufre elementaire aux fins d`attenuation pathogene
US20200396961A1 (en) * 2019-06-18 2020-12-24 Susu Pets, Llc Container for an aqueous composition

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS606882B2 (ja) * 1981-09-17 1985-02-21 光雄 松本 硫黄粉末の微粒化方法
DE3326664A1 (de) * 1982-07-29 1984-02-02 Lilly Industries Ltd., London Fungizides mittel und verfahren zu seiner herstellung
JPS6366105A (ja) * 1986-07-30 1988-03-24 Wada Yoichi 真核細胞生物群の殺菌機構
CA1339133C (fr) * 1987-03-13 1997-07-29 Rikuo Nasu Derives de l'imidazole et compositions a base de ces derives pour l'elimination d'organismes nuisibles
DE4418976C2 (de) * 1994-05-31 1996-12-12 Horst Walter Hendricks Phytotherapeutikum zur Behandlung von Infektionen des Herpes simplex-Virus (Typ 1 und Typ 2) und Verfahren zu seiner Herstellung
DE19624568A1 (de) 1996-06-20 1998-05-14 Hans Lufen Mittel zur topischen Behandlung von Hauterkrankungen
JPH10158155A (ja) * 1996-11-29 1998-06-16 Tac Medical Kk 貼付剤
US5788896A (en) * 1997-02-27 1998-08-04 Alberta Research Council Method of producing micron sized sulphur granules
US5997892A (en) * 1997-10-09 1999-12-07 Camp; Gary Don Topical therapeutic composition for and method of treating psoriasis
JP2000191520A (ja) * 1998-12-31 2000-07-11 Kazuo Sakuma 抗微生物剤
EP0983766A1 (fr) 1999-01-20 2000-03-08 Norbert A. Gschwend Composition pharmaceutique pour le traitement des affections rhumatoides contenant du soufre, des graines de moutarde et un sel de cuivre
CA2265926C (fr) * 1999-04-08 2007-01-02 Airudin S. Khan Methode pour modifier les concentrations d'homocysteine dans le plasma humain
DE19934169A1 (de) 1999-07-21 2001-01-25 Henkel Kgaa Kosmetische und/oder dermatologische Zubereitungen

Also Published As

Publication number Publication date
EP2035018B1 (fr) 2014-10-22
AU2007257286A1 (en) 2007-12-13
WO2007140588A1 (fr) 2007-12-13
CA2654082A1 (fr) 2007-12-13
US20100172992A1 (en) 2010-07-08
CN101500584A (zh) 2009-08-05
CN101500584B (zh) 2012-12-12
JP2009538837A (ja) 2009-11-12
KR101462090B1 (ko) 2014-11-17
KR20090040268A (ko) 2009-04-23
MX2008015200A (es) 2009-02-17
EP2035018A1 (fr) 2009-03-18
AU2007257286B2 (en) 2013-02-21
US20150132390A1 (en) 2015-05-14
JP2013231073A (ja) 2013-11-14
EP2035018A4 (fr) 2009-09-23
CA2654082C (fr) 2015-07-28
NZ597657A (en) 2013-07-26

Similar Documents

Publication Publication Date Title
PL1981516T3 (pl) Zastosowanie mikroorganizmów probiotycznych w leczeniu i zapobieganiu otyłości i pokrewnym zaburzeniom
GB0610350D0 (en) prevention and/or treatment of neuodegenerative disorders
HK1126212A1 (en) Heterocyclic compounds and uses thereof in the treatment of sexual disorders
ZA200806114B (en) Use of sulfonamide derivatives in the treatment of disorders of the metabolism and the nervous system
IL188922A0 (en) Benzoquinazoline derivatives and their use in treating bone disorders
IL184585A0 (en) Prevention and treatment of thromboembolic disorders
EP2205236A4 (fr) Nouveaux agents pour le traitement de troubles et dysfonctionnements
HK1170429A1 (en) Alpha aminoamide derivatives useful in the treatment of cognitive disorders
BRPI0809272A2 (pt) Compostos de biaril e biheteroaril no tratamento de distúrbios do ferro
EP2219448A4 (fr) Composés thérapeutiques et leur utilisation dans le traitement de maladies et de troubles
EP2004216A4 (fr) Agent pour le traitement de troubles hormono-dépendants et utilisations de celui-ci
IL198721A0 (en) Acat inhibitors and their use in the prevention or treatment of fibrosis
HK1130663A1 (en) Use of micron-sized sulphur for the prevention and treatment of pathogenic disorders in humans and animals
IL201426A0 (en) Drug combination and its use in the treatment of muscle loss
IL198134A (en) A combination of antipsychotic drugs and tetracyclines to treat psychiatric illnesses
IL193943A0 (en) The use of beta- aminoalcohols for the treatment of inflammatory disorders and pain
GB0710277D0 (en) Use of antivirals in the treatment of medical disorders
ZA200800035B (en) Prevention and treatment of osteochondrosis in animals and humans
IL193944A0 (en) The use beta-aminoalcohols for the treatment of inflammatory disorders and pain
EP2441452A4 (fr) Composition pharmaceutique et utilisation d'une composition pharmaceutique pour le traitement, la prophylaxie ou la prévention de maladies néoplasiques chez l'homme et l'animal
EP2057997A4 (fr) Agent préventif et/ou thérapeutique pour une neuropathie périphérique
EP1858557A4 (fr) Procédés et compositions permettant de moduler le poids corporel ainsi que de traiter les troubles liés au poids et les maladies associées
GB0513413D0 (en) The treatment of inflammatory disorders and pain
ZA200809417B (en) Prevention and treatment of osteochondrosis in animals and humans
GB0609794D0 (en) The treatment of inflammatory disorders and pain

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20190531